The expanding market for iron-deficiency anemia therapy is driven by the alarming prevalence of anemia worldwide, with iron deficiency accounting for a significant proportion of cases. According to the World Health Organization, an estimated 1.5 to 1.74 billion individuals globally suffer from anemia. The prevalence of iron deficiency anemia is rising, fostering innovation, research, and development in the field while increasing the demand for effective treatments to address this condition.
According to Data Bridge Market Research, the Iron-Deficiency Anemia Therapy Market is USD 3,710.61 million in 2022, is expected to reach USD 13,208.89 million by 2030, at a CAGR of 17.2% during the forecast period 2023 to 2030
“Growing awareness and diagnosis surge market demand"
The growing awareness of iron-deficiency anemia among healthcare professionals and patients has played a crucial role in improving diagnosis rates. With increased knowledge and understanding of the condition's symptoms and risk factors, healthcare providers are better equipped to identify and diagnose iron-deficiency anemia at an earlier stage. Early and accurate diagnosis enables timely intervention and treatment, emphasizing the importance of iron-deficiency anemia therapies and driving the demand for such treatments in the market.
What restraints the growth of the iron-deficiency anemia therapy market?
“Lack of awareness among the general population can impede the market growth”
The general population's lack of awareness about iron-deficiency anemia is a significant restraint for the market. Many individuals may not recognize the symptoms of anemia, such as fatigue, weakness, and shortness of breath, and therefore delay seeking medical help. This delayed diagnosis and treatment can have a negative impact on the demand for therapy, as patients may not receive the necessary treatment in a timely manner. Efforts to increase public awareness about the signs, symptoms, and available treatment options for iron-deficiency anemia are crucial to address this restraint and ensure early intervention for affected individuals.
Segmentation: Global Iron-Deficiency Anemia Therapy Market
The iron-deficiency anemia therapy market is segmented on the basis of type, therapy, therapy areas, population, end-users, and distribution channel
- On the basis of type, the iron-deficiency anemia therapy market is segmented into surface and sub-surface.
- On the basis of therapy, the iron-deficiency anemia therapy market is segmented into parenteral iron therapy, oral iron therapy
- On the basis of therapy areas, the iron-deficiency anemia therapy market is segmented into inflammatory bowel disease, renal, obstetrics, and gynecology, congestive heart failure (CHF), oncology, others
- On the basis of population, the iron-deficiency anemia therapy market is segmented into adults, pediatric, geriatric
- On the basis of end-users, the iron-deficiency anemia therapy market is segmented into hospitals, specialty clinics, homecare, others
- On the basis of distribution channel, the iron-deficiency anemia therapy market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, others
Regional Insights: North America Dominates the Global Iron-Deficiency Anemia Therapy Market
North America's dominance in the iron-deficiency anemia therapy market can be attributed to its well-developed healthcare system, which facilitates better access to diagnosis and treatment. The region's advanced infrastructure and expertise enable timely interventions and patient management. Additionally, the focus of key market players on novel technologies and advancements in iron-deficiency anemia therapies further accelerates the growth rate in North America. This emphasis on innovation enhances treatment outcomes and contributes to the region's market expansion.
Asia-Pacific is expected to grow at the highest growth rate between 2023 and 2030, driven by China's rising demand for large USVs for military and commercial uses like combat operations and cargo transportation.
To know more about the study, visit, https://www.databridgemarketresearch.com/pt/reports/global-iron-deficiency-anemia-therapy-market
Recent Developments in Global Iron-Deficiency Anemia Therapy Market
- In 2021, The first generic high-dose intravenous iron, Ferumoxytol Injection, was made available by Sandoz. In American patients, this medication is used to treat anemia brought on by iron deficiency. Ferumoxytol, a generic version of Feraheme from AMAG Pharmaceuticals, can be used to treat IDA in adults who have an allergy to oral iron, a poor reaction to oral iron, or chronic renal disease.
- In 2022, The New Drug Application (NDA) for Oxemia submitted by Zydus was approved by the Drug Controller General of India. In order to treat anemia associated with chronic kidney disease (CKD), oxyemia, an oral small-molecule inhibitor of hypoxia-inducible factor-prolyl hydroxylase (HIF-PH), is used.
The Prominent Key Players Operating in the Global Iron-Deficiency Anemia Therapy Market Include:
- Fresenius SE & Co. KGaA (Germany)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- AbbVie Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd.(Ireland)
- Lupin (India)
- ViforPharma Ltd. (Switzerland)
- AMAG Pharmaceuticals (U.S.)
- Akebia Therapeutics, INC. (U.S.)
- CHO-A Pharmaceutical CO., LTD. (South Korea)
- Orion Corporation (Finland)
- Pharmacosmos A/S (Denmark)
- Shield Therapeutics (U.K.)
- Advanz Pharmaceutical (U.K.)
- Alkem Labs (India)
- Zydus Cadila (India)
- Hikma Pharmaceuticals PLC (U.K.)
Above are the key players covered in the report, to know about more and exhaustive list of global iron-deficiency anemia therapy market companies contact, https://www.databridgemarketresearch.com/pt/contact
Research Methodology: Global Iron-Deficiency Anemia Therapy Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by dbmr research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.
